DNA-RNA hybrids in inflammation: sources, immune response, and therapeutic implications
Journal of Molecular Medicine · 2025
DOI: 10.1007/s00109-025-02533-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Molecular Medicine, 2025. Verfasst von Litao Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Zhejiang Key Laboratory of Pathophysiology, Health Science Center, Ningbo University, Ningbo, 31521…. Hauptthemen laut MEDLINE: Inflammation, RNA, DNA, Immunity. Die Arbeit nennt 200 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Cytoplasmic DNA-RNA hybrids are emerging as important immunogenic nucleic acids, that were previously underappreciated. DNA-RNA hybrids, formed during cellular processes like transcription and replication, or by exogenous pathogens, are recognized by pattern recognition receptors (PRRs), including cGAS, DDX41, and TLR9, which trigger immune responses. Post-translational modifications (PTMs) including ubiquitination, phosphorylation, acetylation, and palmitoylation regulate the activity of PRRs and downstream signaling molecules, fine-tuning the immune response. Targeting enzymes involved in DNA-RNA hybrid metabolism and PTMs regulation offers therapeutic potential for inflammatory diseases. Herein, we discuss the sources, immune response, and therapeutic implications of DNA-RNA hybrids in inflammation, highlighting the significance of DNA-RNA hybrids as potential targets for the treatment of inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Zhejiang Key Laboratory of Pathophysiology, Health Science Center, Ningbo University, Ningbo, 315211, China.
- Department of Biochemistry and Molecular Biology, Zhejiang Key Laboratory of Pathophysiology, Health Science Center, Ningbo University, Ningbo, 315211, China. yemeng@nbu.edu.cn.
- Department of Biochemistry and Molecular Biology, Zhejiang Key Laboratory of Pathophysiology, Health Science Center, Ningbo University, Ningbo, 315211, China. jinxiaofeng@nbu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Chen, L., Hu, L., Chang, H., Mao, J., Ye, M., & Jin, X. (2025). DNA-RNA hybrids in inflammation: sources, immune response, and therapeutic implications. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-025-02533-0
Vancouver
Chen L, Hu L, Chang H, Mao J, Ye M, Jin X. DNA-RNA hybrids in inflammation: sources, immune response, and therapeutic implications. Journal of Molecular Medicine. 2025. doi:10.1007/s00109-025-02533-0
BibTeX
@article{Chen2025,
author = {Chen, Litao and Hu, Lechen and Chang, Han and Mao, Jianing and Ye, Meng and Jin, Xiaofeng},
title = {DNA-RNA hybrids in inflammation: sources, immune response, and therapeutic implications},
journal = {Journal of Molecular Medicine},
year = {2025},
doi = {10.1007/s00109-025-02533-0}
}
EUVIMED